Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
i c e l t Background. Drug-eluting stents (DESs) have chalenged coronary bypass grafting as the gold standard for -vessel coronary artery disease. This study compared the linical results between percutaneous intervention with ESs vs off-pump coronary bypass surgery (OPCAB). Methods. The study included 388 matched patients ith 3-vessel coronary artery diseases who were treated ither with DESs or OPCAB. We compared 30-day, 12onth, and cumulative major adverse cardiac and cererovascular events (MACCE) during the follow-up. Results. The overall follow-up was 98.5%. Follow-up uration was 621.1 259.9 days (range, 13 to 1117 days). he rates of MAACE in the DES and OPCAB group were, espectively, 1.5% at 30 days (p 0.315) and 9.8% and .6% at 12 months (p 0.015). During follow-up, five eaths occurred in the DES group and one in OPCAB